Persistent psychological distress and mortality in patients with stable coronary artery disease

Heart

Volumn 103, Issue 23, 2017, Pages 1860-1866

  Stewart, Ralph A H ^a   Colquhoun, David M ^b   Marschner, Simone L ^c   Kirby, Adrienne C ^c   Simes, John ^c   Nestel, Paul J ^d   Glozier, Nick ^e   O'Neil, Adrienne ^f,g   Oldenburg, Brian ^g   White, Harvey D ^a   Tonkin, Andrew M ^g  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREENSLOPES PRIVATE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g MONASH UNIVERSITY   (Australia)

Author keywords

anxiety; coronary heart disease; depression; psychological distress

Indexed keywords

PLACEBO; PRAVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALL CAUSE MORTALITY; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); AUSTRALIA; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSIS; DIAGNOSTIC IMAGING; HEART INFARCTION; KAPLAN MEIER METHOD; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY; NEW ZEALAND; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; AUSTRALIA; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ZEALAND; ODDS RATIO; PRAVASTATIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 85021633823     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-311097     Document Type: Article

References (39)

1. N icholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006;27:2763-74.
2. Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010;56:38-46.
3. Denollet J, Schiffer AA, Spek V. A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010;3:546-57.
4. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the american Heart Association. Circulation 2014;129:1350-69.
5. Glozier N, Tofler GH, Colquhoun DM, et al. Psychosocial risk factors for coronary heart disease. Med J Aust 2013;199:179-80.
6. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
7. Hague WE, Simes J, Kirby A, et al. Long-Term Effectiveness and Safety of Pravastatin in Patients with Coronary Heart disease: sixteen years of Follow-Up of the LIPID study. Circulation 2016;133:1851-60.
8. S tewart RA, Sharples KJ, North FM, et al. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. the LIPID study investigators. Arch Intern Med 2000;160:3144-52.
9. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. 1988. Windsor, Berkshire, UK: NFER-Nelson Publishing Company Limited, 1988.
10. S himbo D, Rieckmann N, Paulino R, et al. Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart 2006;92:1316-8.
11. van Hemert AM, den Heijer M, Vorstenbosch M, et al. Detecting psychiatric disorders in medical practice using the General Health Questionnaire. why do cut-off scores vary? Psychol Med 1995;25:165-70.
12. Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol 2001;38:56-63.
13. Fine JP, Gray RJ. A proportional hazards Model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
14. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
15. Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
16. Russ TC, Stamatakis E, Hamer M, et al. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ 2012;345:e4933.
17. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953-62.
18. Gustad LT, Laugsand LE, Janszky I, et al. Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study. Eur Heart J 2014;35:1394-403.
19. Brunner EJ, Shipley MJ, Britton AR, et al. Depressive disorder, coronary heart disease, and stroke: dose-response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol 2014;21:340-6.
20. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary Heart Disease patients (ENRICHD) Randomized trial. JAMA 2003;289:3106-16.
21. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of Major depression in patients with Acute MI or Unstable angina. JAMA 2002;288:701-9.
22. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the enhancing recovery in coronary Heart disease (ENRICHD) study. Psychosom Med 2004;66:466-74.
23. de Jonge P, Honig A, van Melle JP, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007;164:1371-8.
24. Glassman AH, Bigger JT, Gaffney M. Psychiatric characteristics associated with longterm mortality among 361 patients having an acute coronary syndrome and Major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009;66:1022-9.
25. Tonkin AM, Blankenberg S, Kirby A, et al. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: the LIPID biomarker study. Int J Cardiol 2015;201:499-507.
26. Maes M, Bosmans E, De Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in Major depression and treatment resistant depression. Cytokine 1997;9:853-8.
27. Paterniti S, Zureik M, Ducimetière P, et al. Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:136-41.
28. Prugger C, Godin O, Perier MC, et al. Longitudinal association of carotid plaque presence and intima-media thickness with depressive symptoms in the elderly: the three-city study. Arterioscler Thromb Vasc Biol 2015;35:1279-83.
29. O'Malley PG, Jones DL, Feuerstein IM, et al. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med 2000;343:1298-304.
30. Mittleman MA, Mostofsky E, Physical ME. Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation 2011;124:346-54.
31. S teptoe A, Strike PC, Perkins-Porras L, et al. Acute depressed mood as a trigger of acute coronary syndromes. Biol Psychiatry 2006;60:837-42.
32. S tewart RA, North FM, West TM, et al. Depression and cardiovascular morbidity and mortality: cause or consequence? Eur Heart J 2003;24:2027-37.
33. Virtanen M, Elovainio M, Josefsson K, et al. Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age. Heart 2017;103.
34. E dmondson D, Kronish IM, Shaffer JA, et al. Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J 2013;166:806-14.
35. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary Heart Disease patients (ENRICHD) Randomized trial. JAMA 2003;289:3106-16.
36. van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007;190:460-6.
37. Davidson KW, Rieckmann N, Clemow L, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010;170:600-8.
38. Unützer J, Katon W, Callahan CM, et al. Collaborative care management of latelife depression in the primary care setting: a randomized controlled trial. Jama 2002;288:2836-45.
39. Colquhoun DM, Bunker SJ, Clarke DM, et al. Screening, referral and treatment for depression in patients with coronary heart disease. Med J Aust 2013;198:483-4.